Mr. Vivek Seigell is a senior business and public-policy professional with extensive experience across healthcare, pharmaceuticals, education, technology, and business strategy. He currently serves as Senior Vice President, Apeejay Stya & Svran Group, and as advisor to Walter Bushnell, the group’s pharmaceutical business. His professional profile describes nearly four decades of experience across leadership and strategic roles.

At Walter Bushnell, Mr. Seigell contributes to strategic initiatives within the pharmaceutical sector. Walter Bushnell is part of the Svran Group’s pharmaceutical vertical and has a long-standing presence in India’s pharmaceutical industry, with a focus on science-led promotion and innovative therapies.

Mr. Seigell has a strong interest in healthcare policy, pharmaceuticals, public health, innovation, and business-government engagement. His recent professional activities include discussions involving healthcare manufacturing, pharmaceutical policy, medical technology, regulatory frameworks, and health-system development.

He is also associated with Apeejay School of Management, where he is listed as Prof. Vivek Seigell—Public Policy Expert, Business, and Economic Growth. This reflects his broader role in mentoring and contributing to discussions around public policy, management, economic development, and business strategy.

Mr. Seigell has participated in prominent healthcare and pharmaceutical forums. He has served as a jury member for the ETHealthWorld National Fertility Awards and ET Re-Pharma Awards, bringing his experience in healthcare leadership and industry strategy to the evaluation of innovation and excellence in healthcare and pharmaceuticals.

His professional background also includes engagement with government and industry policy initiatives. He has written and spoken about healthcare access, pharmaceutical innovation, regulatory reform, digital transformation, and India’s position as a global healthcare and pharmaceutical hub. His public profile shows interactions with senior policymakers and international business delegations on healthcare and economic issues.